Close Menu

So Quick

Many researchers are developing lab-on-a-chip devices that can be used to identify viruses, chemicals, or chromosomal aberrations using just a drop of blood, writes Alok Jha at The Guardian. "The platform blurs nanotechnology, biotechnology, and micro-electronics. And it is not specific to medicine," he says. The advantage of this approach is that not only can it be done outside of a lab, but it also requires small samples.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR reports the US Food and Drug Administration has approved a treatment for a genetic disorder that causes rapid aging.

Late-stage testing indicates the AstraZeneca and Oxford University SARS-CoV-2 vaccine can have up to 90 percent efficacy, the Associated Press reports.

ScienceInsider reports Nature Communications is reviewing a paper on mentorship following social media criticism arguing it is sexist.

In PLOS this week: method to account for sequencing errors in phylogenies, study of influenza A in Switzerland, and more.